HB1638
View on ILGACONTROLLED SUB-SCHEDULE II
What this bill does
Amends the Illinois Controlled Substances Act. Provides that any person, other than the person for whom a Schedule II controlled substance is prescribed, who receives the prescribed Schedule II controlled substance at a pharmacy shall provide: (1) identifying information of the person for whom the controlled substance is prescribed; and (2) photo identification given to the pharmacy, which shall keep a photo copy in the file of the person for whom the controlled substance is prescribed for a period of 90 days.
Calculating prediction drivers...
Pipeline Progress
Current stage: In Committee · Last action 384 days ago · STAGNANT
How does a bill become law in Illinois?
-
Introduction of Bill
A member of the Senate or the House introduces a bill, which is assigned a unique identifying number (e.g., "H.B. ___" for House bills and "S.B. ___" for Senate bills). If not enacted, it must be reintroduced in the next General Assembly with a new number.
-
Committee Work — Hearings
The bill goes to the appropriate committee, which holds hearings to gather expert opinions and determine the need for the legislation.
-
Committee Work — Markup, Amendments, Report
The committee may make amendments to the bill. If approved, a committee report endorsing the bill is issued.
-
Floor Debate
The bill is debated and can be further amended. The debate transcripts are accessible online for public viewing.
-
Passage and Consideration in Second Chamber
If the bill passes in the first chamber, it moves to the second chamber for a similar review process. If both chambers approve, it goes to the governor.
-
Gubernatorial Action
The governor can sign the bill into law, veto it, or take no action (resulting in an automatic law after 60 days). The type of veto can be total or amendatory. Once signed, the bill becomes a Public Act and is assigned a Public Act number.
Sponsor Context
Hearings
This bill has not been scheduled for a committee hearing.
Witness slips
9 slips filed. Proponent / opponent / no position as filed with the committee.
| Name | Organization | Representing | Position | Hearing committee | Hearing date |
|---|---|---|---|---|---|
| Garth Reynolds | Illinois Pharmacists Association | Illinois Pharmacists Association | Opponent | Health Care Licenses | 2025-03-20 |
| Andrew Lee | Self | Self | Opponent | Health Care Licenses | 2025-03-19 |
| Rob Karr | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Health Care Licenses | 2025-03-19 |
| Alec Laird | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Health Care Licenses | 2025-03-12 |
| Garth Reynolds | Illinois Pharmacists Association | Illinois Pharmacists Association | Opponent | Health Care Licenses | 2025-03-12 |
| Alec Laird | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Health Care Licenses | 2025-03-05 |
| Garth Reynolds | Illinois Pharmacists Association | Illinois Pharmacists Association | Opponent | Health Care Licenses | 2025-03-05 |
| Alec Laird | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Health Care Licenses | 2025-02-26 |
| Garth Reynolds | Illinois Pharmacists Association | Illinois Pharmacists Association | Opponent | Health Care Licenses | 2025-02-26 |
Action History
11 actions recorded. Last action: 2025-03-21 — Rule 19(a) / Re-referred toRules Committee. Each action's meaning and outcome signal are classified automatically.
All actions (table)
| Date | Chamber | Action | Category | Signal |
|---|---|---|---|---|
| 2025-01-23 | House | Filed with the Clerk byRep. Amy L. Grant House Rule 6(b) | Introduction & Filing | — |
| 2025-01-28 | House | First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38 | Introduction & Filing | — |
| 2025-01-28 | House | Referred toRules Committee Senate Rule 3-8(a); House Rule 18(a) | Committee Assignment | — |
| 2025-02-10 | House | Added Co-SponsorRep. Tony M. McCombie Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-02-18 | House | Assigned toHealth Care Licenses Committee Senate Rule 3-8(a); House Rule 18(b) | Committee Assignment | — |
| 2025-02-26 | House | Added Co-SponsorRep. Jackie Haas Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-02-27 | House | Added Chief Co-SponsorRep. Travis Weaver Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-02-27 | House | Added Chief Co-SponsorRep. Brad Stephens Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-02-27 | House | Added Co-SponsorRep. Amy Elik Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-02-27 | House | Added Co-SponsorRep. Brad Halbrook Senate Rule 5-1(a); House Rule 37(a) | Co-Sponsorship | Mild + |
| 2025-03-21 | House | Rule 19(a) / Re-referred toRules Committee House Rule 19(a); Senate analog: Rule 3-9(a) | Deadlines & Re-referrals | Mild − |